Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)
Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Schutte, Elise [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested - 2013, AJKD : official journal of the National Kidney Foundation, Philadelphia, Pa |
|---|---|
| Übergeordnetes Werk: |
volume:66 ; year:2015 ; number:3 ; pages:450-458 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1053/j.ajkd.2015.03.032 |
|---|
| Katalog-ID: |
ELV03450155X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV03450155X | ||
| 003 | DE-627 | ||
| 005 | 20230624013738.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.ajkd.2015.03.032 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015008000003.pica |
| 035 | |a (DE-627)ELV03450155X | ||
| 035 | |a (ELSEVIER)S0272-6386(15)00625-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DNB |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 530 |q VZ |
| 084 | |a 52.56 |2 bkl | ||
| 100 | 1 | |a Schutte, Elise |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) |
| 264 | 1 | |c 2015 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. | ||
| 650 | 7 | |a risk predictor |2 Elsevier | |
| 650 | 7 | |a cardiovascular disease |2 Elsevier | |
| 650 | 7 | |a metabolic acidosis |2 Elsevier | |
| 650 | 7 | |a type 2 diabetes |2 Elsevier | |
| 650 | 7 | |a kidney disease progression |2 Elsevier | |
| 650 | 7 | |a Diabetes mellitus |2 Elsevier | |
| 650 | 7 | |a end-stage renal disease (ESRD) |2 Elsevier | |
| 650 | 7 | |a serum bicarbonate |2 Elsevier | |
| 650 | 7 | |a mortality |2 Elsevier | |
| 650 | 7 | |a diabetic nephropathy |2 Elsevier | |
| 700 | 1 | |a Lambers Heerspink, Hiddo J. |4 oth | |
| 700 | 1 | |a Lutgers, Helen L. |4 oth | |
| 700 | 1 | |a Bakker, Stephan J.L. |4 oth | |
| 700 | 1 | |a Vart, Priya |4 oth | |
| 700 | 1 | |a Wolffenbuttel, Bruce H.R. |4 oth | |
| 700 | 1 | |a Umanath, Kausik |4 oth | |
| 700 | 1 | |a Lewis, Julia B. |4 oth | |
| 700 | 1 | |a de Zeeuw, Dick |4 oth | |
| 700 | 1 | |a Gansevoort, Ron T. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Saunders |t The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested |d 2013 |d AJKD : official journal of the National Kidney Foundation |g Philadelphia, Pa |w (DE-627)ELV011405082 |
| 773 | 1 | 8 | |g volume:66 |g year:2015 |g number:3 |g pages:450-458 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1053/j.ajkd.2015.03.032 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 52.56 |j Regenerative Energieformen |j alternative Energieformen |q VZ |
| 951 | |a AR | ||
| 952 | |d 66 |j 2015 |e 3 |h 450-458 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
e s es |
|---|---|
| matchkey_str |
schutteeliselambersheerspinkhiddojlutger:2015----:eubcroaenkdedsaergesoadadoaclrucmiptetwtdaeinprptypshcnlssfhrnardcinfnpitinnnuidpnetibtsihhagoesn |
| hierarchy_sort_str |
2015 |
| bklnumber |
52.56 |
| publishDate |
2015 |
| allfields |
10.1053/j.ajkd.2015.03.032 doi GBVA2015008000003.pica (DE-627)ELV03450155X (ELSEVIER)S0272-6386(15)00625-3 DE-627 ger DE-627 rakwb eng 610 610 DNB 610 VZ 530 VZ 52.56 bkl Schutte, Elise verfasserin aut Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Elsevier Lambers Heerspink, Hiddo J. oth Lutgers, Helen L. oth Bakker, Stephan J.L. oth Vart, Priya oth Wolffenbuttel, Bruce H.R. oth Umanath, Kausik oth Lewis, Julia B. oth de Zeeuw, Dick oth Gansevoort, Ron T. oth Enthalten in Elsevier Saunders The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested 2013 AJKD : official journal of the National Kidney Foundation Philadelphia, Pa (DE-627)ELV011405082 volume:66 year:2015 number:3 pages:450-458 extent:9 https://doi.org/10.1053/j.ajkd.2015.03.032 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_40 52.56 Regenerative Energieformen alternative Energieformen VZ AR 66 2015 3 450-458 9 045F 610 |
| spelling |
10.1053/j.ajkd.2015.03.032 doi GBVA2015008000003.pica (DE-627)ELV03450155X (ELSEVIER)S0272-6386(15)00625-3 DE-627 ger DE-627 rakwb eng 610 610 DNB 610 VZ 530 VZ 52.56 bkl Schutte, Elise verfasserin aut Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Elsevier Lambers Heerspink, Hiddo J. oth Lutgers, Helen L. oth Bakker, Stephan J.L. oth Vart, Priya oth Wolffenbuttel, Bruce H.R. oth Umanath, Kausik oth Lewis, Julia B. oth de Zeeuw, Dick oth Gansevoort, Ron T. oth Enthalten in Elsevier Saunders The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested 2013 AJKD : official journal of the National Kidney Foundation Philadelphia, Pa (DE-627)ELV011405082 volume:66 year:2015 number:3 pages:450-458 extent:9 https://doi.org/10.1053/j.ajkd.2015.03.032 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_40 52.56 Regenerative Energieformen alternative Energieformen VZ AR 66 2015 3 450-458 9 045F 610 |
| allfields_unstemmed |
10.1053/j.ajkd.2015.03.032 doi GBVA2015008000003.pica (DE-627)ELV03450155X (ELSEVIER)S0272-6386(15)00625-3 DE-627 ger DE-627 rakwb eng 610 610 DNB 610 VZ 530 VZ 52.56 bkl Schutte, Elise verfasserin aut Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Elsevier Lambers Heerspink, Hiddo J. oth Lutgers, Helen L. oth Bakker, Stephan J.L. oth Vart, Priya oth Wolffenbuttel, Bruce H.R. oth Umanath, Kausik oth Lewis, Julia B. oth de Zeeuw, Dick oth Gansevoort, Ron T. oth Enthalten in Elsevier Saunders The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested 2013 AJKD : official journal of the National Kidney Foundation Philadelphia, Pa (DE-627)ELV011405082 volume:66 year:2015 number:3 pages:450-458 extent:9 https://doi.org/10.1053/j.ajkd.2015.03.032 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_40 52.56 Regenerative Energieformen alternative Energieformen VZ AR 66 2015 3 450-458 9 045F 610 |
| allfieldsGer |
10.1053/j.ajkd.2015.03.032 doi GBVA2015008000003.pica (DE-627)ELV03450155X (ELSEVIER)S0272-6386(15)00625-3 DE-627 ger DE-627 rakwb eng 610 610 DNB 610 VZ 530 VZ 52.56 bkl Schutte, Elise verfasserin aut Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Elsevier Lambers Heerspink, Hiddo J. oth Lutgers, Helen L. oth Bakker, Stephan J.L. oth Vart, Priya oth Wolffenbuttel, Bruce H.R. oth Umanath, Kausik oth Lewis, Julia B. oth de Zeeuw, Dick oth Gansevoort, Ron T. oth Enthalten in Elsevier Saunders The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested 2013 AJKD : official journal of the National Kidney Foundation Philadelphia, Pa (DE-627)ELV011405082 volume:66 year:2015 number:3 pages:450-458 extent:9 https://doi.org/10.1053/j.ajkd.2015.03.032 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_40 52.56 Regenerative Energieformen alternative Energieformen VZ AR 66 2015 3 450-458 9 045F 610 |
| allfieldsSound |
10.1053/j.ajkd.2015.03.032 doi GBVA2015008000003.pica (DE-627)ELV03450155X (ELSEVIER)S0272-6386(15)00625-3 DE-627 ger DE-627 rakwb eng 610 610 DNB 610 VZ 530 VZ 52.56 bkl Schutte, Elise verfasserin aut Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Elsevier Lambers Heerspink, Hiddo J. oth Lutgers, Helen L. oth Bakker, Stephan J.L. oth Vart, Priya oth Wolffenbuttel, Bruce H.R. oth Umanath, Kausik oth Lewis, Julia B. oth de Zeeuw, Dick oth Gansevoort, Ron T. oth Enthalten in Elsevier Saunders The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested 2013 AJKD : official journal of the National Kidney Foundation Philadelphia, Pa (DE-627)ELV011405082 volume:66 year:2015 number:3 pages:450-458 extent:9 https://doi.org/10.1053/j.ajkd.2015.03.032 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_40 52.56 Regenerative Energieformen alternative Energieformen VZ AR 66 2015 3 450-458 9 045F 610 |
| language |
English |
| source |
Enthalten in The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested Philadelphia, Pa volume:66 year:2015 number:3 pages:450-458 extent:9 |
| sourceStr |
Enthalten in The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested Philadelphia, Pa volume:66 year:2015 number:3 pages:450-458 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Regenerative Energieformen alternative Energieformen |
| institution |
findex.gbv.de |
| topic_facet |
risk predictor cardiovascular disease metabolic acidosis type 2 diabetes kidney disease progression Diabetes mellitus end-stage renal disease (ESRD) serum bicarbonate mortality diabetic nephropathy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested |
| authorswithroles_txt_mv |
Schutte, Elise @@aut@@ Lambers Heerspink, Hiddo J. @@oth@@ Lutgers, Helen L. @@oth@@ Bakker, Stephan J.L. @@oth@@ Vart, Priya @@oth@@ Wolffenbuttel, Bruce H.R. @@oth@@ Umanath, Kausik @@oth@@ Lewis, Julia B. @@oth@@ de Zeeuw, Dick @@oth@@ Gansevoort, Ron T. @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011405082 |
| dewey-sort |
3610 |
| id |
ELV03450155X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03450155X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624013738.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.ajkd.2015.03.032</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015008000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03450155X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0272-6386(15)00625-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">52.56</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schutte, Elise</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">risk predictor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cardiovascular disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">metabolic acidosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">type 2 diabetes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">kidney disease progression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetes mellitus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">end-stage renal disease (ESRD)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">serum bicarbonate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mortality</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">diabetic nephropathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lambers Heerspink, Hiddo J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lutgers, Helen L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bakker, Stephan J.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vart, Priya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolffenbuttel, Bruce H.R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Umanath, Kausik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lewis, Julia B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Zeeuw, Dick</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gansevoort, Ron T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Saunders</subfield><subfield code="t">The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested</subfield><subfield code="d">2013</subfield><subfield code="d">AJKD : official journal of the National Kidney Foundation</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV011405082</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:66</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:450-458</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1053/j.ajkd.2015.03.032</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">52.56</subfield><subfield code="j">Regenerative Energieformen</subfield><subfield code="j">alternative Energieformen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">66</subfield><subfield code="j">2015</subfield><subfield code="e">3</subfield><subfield code="h">450-458</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Schutte, Elise |
| spellingShingle |
Schutte, Elise ddc 610 ddc 530 bkl 52.56 Elsevier risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) |
| authorStr |
Schutte, Elise |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011405082 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 530 - Physics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DNB 610 VZ 530 VZ 52.56 bkl Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy Elsevier |
| topic |
ddc 610 ddc 530 bkl 52.56 Elsevier risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy |
| topic_unstemmed |
ddc 610 ddc 530 bkl 52.56 Elsevier risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy |
| topic_browse |
ddc 610 ddc 530 bkl 52.56 Elsevier risk predictor Elsevier cardiovascular disease Elsevier metabolic acidosis Elsevier type 2 diabetes Elsevier kidney disease progression Elsevier Diabetes mellitus Elsevier end-stage renal disease (ESRD) Elsevier serum bicarbonate Elsevier mortality Elsevier diabetic nephropathy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h h j l hhj hhjl h l l hl hll s j b sj sjb p v pv b h w bh bhw k u ku j b l jb jbl z d d zd zdd r t g rt rtg |
| hierarchy_parent_title |
The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested |
| hierarchy_parent_id |
ELV011405082 |
| dewey-tens |
610 - Medicine & health 530 - Physics |
| hierarchy_top_title |
The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011405082 |
| title |
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) |
| ctrlnum |
(DE-627)ELV03450155X (ELSEVIER)S0272-6386(15)00625-3 |
| title_full |
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) |
| author_sort |
Schutte, Elise |
| journal |
The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested |
| journalStr |
The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
450 |
| author_browse |
Schutte, Elise |
| container_volume |
66 |
| physical |
9 |
| class |
610 610 DNB 610 VZ 530 VZ 52.56 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Schutte, Elise |
| doi_str_mv |
10.1053/j.ajkd.2015.03.032 |
| dewey-full |
610 530 |
| title_sort |
serum bicarbonate and kidney disease progression and cardiovascular outcome in patients with diabetic nephropathy: a post hoc analysis of the renaal (reduction of end points in non–insulin-dependent diabetes with the angiotensin ii antagonist losartan) study and idnt (irbesartan diabetic nephropathy trial) |
| title_auth |
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) |
| abstract |
Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. |
| abstractGer |
Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. |
| abstract_unstemmed |
Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_40 |
| container_issue |
3 |
| title_short |
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial) |
| url |
https://doi.org/10.1053/j.ajkd.2015.03.032 |
| remote_bool |
true |
| author2 |
Lambers Heerspink, Hiddo J. Lutgers, Helen L. Bakker, Stephan J.L. Vart, Priya Wolffenbuttel, Bruce H.R. Umanath, Kausik Lewis, Julia B. de Zeeuw, Dick Gansevoort, Ron T. |
| author2Str |
Lambers Heerspink, Hiddo J. Lutgers, Helen L. Bakker, Stephan J.L. Vart, Priya Wolffenbuttel, Bruce H.R. Umanath, Kausik Lewis, Julia B. de Zeeuw, Dick Gansevoort, Ron T. |
| ppnlink |
ELV011405082 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1053/j.ajkd.2015.03.032 |
| up_date |
2024-07-06T21:16:50.714Z |
| _version_ |
1803865933182140416 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03450155X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624013738.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.ajkd.2015.03.032</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015008000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03450155X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0272-6386(15)00625-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">52.56</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schutte, Elise</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Low serum bicarbonate level has been reported to be an independent predictor of kidney function decline and mortality in patients with chronic kidney disease. Mechanisms underlying low serum bicarbonate levels may differ in patients with and without diabetes. We aimed to specifically investigate the association of serum bicarbonate level with kidney disease progression and cardiovascular outcome in a cohort of patients with type 2 diabetes and nephropathy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">risk predictor</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cardiovascular disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">metabolic acidosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">type 2 diabetes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">kidney disease progression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetes mellitus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">end-stage renal disease (ESRD)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">serum bicarbonate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mortality</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">diabetic nephropathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lambers Heerspink, Hiddo J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lutgers, Helen L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bakker, Stephan J.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vart, Priya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolffenbuttel, Bruce H.R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Umanath, Kausik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lewis, Julia B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Zeeuw, Dick</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gansevoort, Ron T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Saunders</subfield><subfield code="t">The Audio Recorded Cognitive Screen: Outpatient reports on the experience of being tested</subfield><subfield code="d">2013</subfield><subfield code="d">AJKD : official journal of the National Kidney Foundation</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV011405082</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:66</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:450-458</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1053/j.ajkd.2015.03.032</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">52.56</subfield><subfield code="j">Regenerative Energieformen</subfield><subfield code="j">alternative Energieformen</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">66</subfield><subfield code="j">2015</subfield><subfield code="e">3</subfield><subfield code="h">450-458</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.397996 |